Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Assets Average (2020 - 2025)

Goldenwell Biotech's Assets Average history spans 6 years, with the latest figure at $235852.5 for Q3 2025.

  • For Q3 2025, Assets Average rose 24.19% year-over-year to $235852.5; the TTM value through Sep 2025 reached $235852.5, up 24.19%, while the annual FY2024 figure was $226143.0, 5.08% down from the prior year.
  • Assets Average reached $235852.5 in Q3 2025 per GWLL's latest filing, up from $221605.0 in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $497511.5 in Q3 2021 to a low of $189636.0 in Q3 2023.
  • Average Assets Average over 5 years is $278748.5, with a median of $233911.0 recorded in 2023.
  • Peak YoY movement for Assets Average: soared 89.7% in 2021, then tumbled 45.68% in 2022.
  • A 5-year view of Assets Average shows it stood at $473413.0 in 2021, then plummeted by 45.66% to $257238.5 in 2022, then fell by 19.33% to $207513.5 in 2023, then dropped by 2.75% to $201812.0 in 2024, then increased by 16.87% to $235852.5 in 2025.
  • Per Business Quant, the three most recent readings for GWLL's Assets Average are $235852.5 (Q3 2025), $221605.0 (Q2 2025), and $208053.5 (Q1 2025).